Kari Natunen

Tampere, Finland

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 21 publications

Prostate Cancer Screening With PSA, Kallikrein Panel, and MRI: The ProScreen Randomized Trial.

Prostate Cancer Screening With PSA, Kallikrein Panel, and MRI: The ProScreen Randomized Trial.

Journal: JAMA

Published: April 06, 2024

Early detection of clinically significant prostate cancer: protocol summary and statistical analysis plan for the ProScreen randomised trial.

Early detection of clinically significant prostate cancer: protocol summary and statistical analysis plan for the ProScreen randomised trial.

Journal: BMJ open

Published: January 09, 2024

Expected impact of MRI-targeted biopsy interreader variability among uropathologists on ProScreen prostate cancer screening trial: a pre-trial validation study.

Expected impact of MRI-targeted biopsy interreader variability among uropathologists on ProScreen prostate cancer screening trial: a pre-trial validation study.

Journal: World journal of urology

Published: November 08, 2023

Population-based randomized trial of screening for clinically significant prostate cancer ProScreen: a pilot study.

Population-based randomized trial of screening for clinically significant prostate cancer ProScreen: a pilot study.

Journal: BJU international

Published: December 27, 2021

Effectiveness of various human papillomavirus vaccination strategies: A community randomized trial in Finland.

Effectiveness of various human papillomavirus vaccination strategies: A community randomized trial in Finland.

Journal: Cancer medicine

Published: May 20, 2021

Expected impact of MRI-related interreader variability on ProScreen prostate cancer screening trial: a pre-trial validation study.

Expected impact of MRI-related interreader variability on ProScreen prostate cancer screening trial: a pre-trial validation study.

Journal: Cancer imaging : the official publication of the International Cancer Imaging Society

Published: April 07, 2020

Vaccination With Moderate Coverage Eradicates Oncogenic Human Papillomaviruses If a Gender-Neutral Strategy Is Applied.

Vaccination With Moderate Coverage Eradicates Oncogenic Human Papillomaviruses If a Gender-Neutral Strategy Is Applied.

Journal: The Journal of infectious diseases

Published: November 01, 2019

The Prevalence of HSV, HHV-6, HPV and Mycoplasma genitalium in Chlamydia trachomatis positive and Chlamydia trachomatis Negative Urogenital Samples among Young Women in Finland.

The Prevalence of HSV, HHV-6, HPV and Mycoplasma genitalium in Chlamydia trachomatis positive and Chlamydia trachomatis Negative Urogenital Samples among Young Women in Finland.

Journal: Pathogens (Basel, Switzerland)

Published: October 30, 2019

Effectiveness of the AS04-adjuvanted HPV-16/18 vaccine in reducing oropharyngeal HPV infections in young females-Results from a community-randomized trial.

Effectiveness of the AS04-adjuvanted HPV-16/18 vaccine in reducing oropharyngeal HPV infections in young females-Results from a community-randomized trial.

Journal: International journal of cancer

Published: July 18, 2019

Gender-neutral vaccination provides improved control of human papillomavirus types 18/31/33/35 through herd immunity: Results of a community randomized trial (III).

Gender-neutral vaccination provides improved control of human papillomavirus types 18/31/33/35 through herd immunity: Results of a community randomized trial (III).

Journal: International journal of cancer

Published: January 26, 2018

Vaccination protects against invasive HPV-associated cancers.

Vaccination protects against invasive HPV-associated cancers.

Journal: International journal of cancer

Published: October 20, 2017

Evaluation of HPV type-replacement in unvaccinated and vaccinated adolescent females-Post-hoc analysis of a community-randomized clinical trial (II).

Evaluation of HPV type-replacement in unvaccinated and vaccinated adolescent females-Post-hoc analysis of a community-randomized clinical trial (II).

Journal: International journal of cancer

Published: September 08, 2017

Showing 1-12 of 21

Last Updated: 09/26/2026